Shopping Cart
- Remove All
- Your shopping cart is currently empty
Glecirasib (KRAS G12C inhibitor 36) is a potent inhibitor of the oncogenic KRAS G12C mutation, a critical Ras protein crucial for cell growth and development. This compound shows promise for investigating cancers mediated by KRAS G12C mutations[1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
25 mg | $6,989 | 4-6 weeks | |
50 mg | $9,789 | 4-6 weeks | |
100 mg | $13,728 | 4-6 weeks |
Description | Glecirasib (KRAS G12C inhibitor 36) is a potent inhibitor of the oncogenic KRAS G12C mutation, a critical Ras protein crucial for cell growth and development. This compound shows promise for investigating cancers mediated by KRAS G12C mutations[1]. |
Alias | KRAS G12C inhibitor 36, JAB-21822 |
Molecular Weight | 640.03 |
Formula | C31H26ClF4N7O2 |
Cas No. | 2657613-87-9 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.